Attached files
| file | filename |
|---|---|
| 10-K - 10-K - NextCure, Inc. | nxtc-20191231x10k.htm |
| EX-32.1 - EX-32.1 - NextCure, Inc. | nxtc-20191231ex321f4a41a.htm |
| EX-31.2 - EX-31.2 - NextCure, Inc. | nxtc-20191231ex3127a5bf5.htm |
| EX-31.1 - EX-31.1 - NextCure, Inc. | nxtc-20191231ex3113ff49f.htm |
| EX-4.2 - EX-4.2 - NextCure, Inc. | nxtc-20191231ex42d841f91.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
(1) |
Registration Statement (Form S-8 No. 333-231438) pertaining to the NextCure, Inc. 2019 Employee Stock Purchase Plan; and |
|
(2) |
Registration Statement (Form S-8 No. 333-231436) pertaining to the NextCure, Inc. 2015 Omnibus Incentive Plan and the NextCure, Inc. 2019 Omnibus Incentive Plan; |
of our report dated March 12, 2020, with respect to the financial statements of NextCure, Inc. included in this Annual Report (Form 10-K) of NextCure, Inc. for the year ended December 31, 2019.
|
/s/ Ernst & Young LLP |
|
|
|
|
|
Baltimore, Maryland |
|
|
March 12, 2020 |
|